XML 169 R127.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Financial Information for Guarantor Subsidiaries and Non-Guarantor Subsidiaries - Supplemental Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities $ 546.0 $ 346.0 $ 507.0
Cash flows from investing activities:      
Capital expenditures (285.0) (391.0) (294.0)
Distributions of capital from equity investments 23.0 30.0 34.0
Acquisitions and additions to equity method investments (1.0) (180.0) (107.0)
Other, principally change in intercompany investing activities 0.0    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     10.0
Payments for (Proceeds from) Other Investing Activities   0.0 0.0
Payments to Acquire Businesses, Net of Cash Acquired 0.0 (297.0) (58.0)
Proceeds from Sales of Assets, Investing Activities   40.0  
Net cash used in investing activities (263.0) (798.0) (415.0)
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds (397.0) 238.0 (415.0)
Net Payments For (Proceeds From) Long-Term Debt     (701.0)
Payments of debt issuance and deferred financing costs 35.0 38.0 59.0
Payments on license obligations (40.0) (45.0) (53.0)
Sale of future revenue 11.0    
Net proceeds from the sale of SciPlay common stock 342.0 0.0 0.0
Payments of deferred SciPlay common stock offering costs (9.0) 0.0 0.0
Net redemptions of common stock under stock-based compensation plans and other (1.0) (21.0) (9.0)
Other, principally change in intercompany financing activities 0.0 0.0 0.0
Payments of assumed NYX debt and other acquisitions debt 0.0 (290.0) 0.0
Payment of Financing and Stock Issuance Costs   (38.0) (59.0)
Net cash (used in) provided by financing activities (129.0) (156.0) 580.0
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.0 (6.0) 5.0
Increase (decrease) in cash, cash equivalents and restricted cash 155.0 (614.0) 677.0
Cash, cash equivalents and restricted cash, beginning of period 220.0 834.0 157.0
Cash, cash equivalents and restricted cash, end of period 375.0 220.0 834.0
Reportable Legal Entities | Parent Company      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities (57.0) (221.0) (41.0)
Cash flows from investing activities:      
Capital expenditures (22.0) (35.0) (53.0)
Distributions of capital from equity investments 0.0 0.0 0.0
Acquisitions and additions to equity method investments 0.0 0.0 0.0
Other, principally change in intercompany investing activities 0.0    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     0.0
Payments for (Proceeds from) Other Investing Activities   0.0 0.0
Payments to Acquire Businesses, Net of Cash Acquired   0.0 0.0
Proceeds from Sales of Assets, Investing Activities   0.0  
Net cash used in investing activities (22.0) (35.0)  
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds 0.0 0.0 (53.0)
Net Payments For (Proceeds From) Long-Term Debt     250.0
Payments of debt issuance and deferred financing costs 0.0    
Payments on license obligations (27.0) (43.0) (48.0)
Sale of future revenue 0.0    
Net proceeds from the sale of SciPlay common stock 0.0    
Payments of deferred SciPlay common stock offering costs 0.0    
Net redemptions of common stock under stock-based compensation plans and other 7.0 (18.0) (8.0)
Other, principally change in intercompany financing activities 122.0 (342.0) 1,100.0
Payments of assumed NYX debt and other acquisitions debt   0.0  
Payment of Financing and Stock Issuance Costs   0.0 0.0
Net cash (used in) provided by financing activities 102.0 (403.0) 794.0
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0.0 0.0 0.0
Increase (decrease) in cash, cash equivalents and restricted cash 23.0 (659.0) 700.0
Cash, cash equivalents and restricted cash, beginning of period 74.0 733.0 33.0
Cash, cash equivalents and restricted cash, end of period 97.0 74.0 733.0
Reportable Legal Entities | Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 109.0 206.0 567.0
Cash flows from investing activities:      
Capital expenditures (112.0) (146.0) (129.0)
Distributions of capital from equity investments 0.0 0.0 0.0
Acquisitions and additions to equity method investments 0.0 0.0 0.0
Other, principally change in intercompany investing activities 0.0    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     8.0
Payments for (Proceeds from) Other Investing Activities   0.0 0.0
Payments to Acquire Businesses, Net of Cash Acquired   (32.0) (26.0)
Proceeds from Sales of Assets, Investing Activities   40.0  
Net cash used in investing activities (112.0) (138.0)  
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds 0.0 0.0 (147.0)
Net Payments For (Proceeds From) Long-Term Debt     0.0
Payments of debt issuance and deferred financing costs 0.0    
Payments on license obligations (10.0) (2.0) (5.0)
Sale of future revenue 11.0    
Net proceeds from the sale of SciPlay common stock 0.0    
Payments of deferred SciPlay common stock offering costs 0.0    
Net redemptions of common stock under stock-based compensation plans and other (4.0) (3.0) (1.0)
Other, principally change in intercompany financing activities 15.0 (62.0) (411.0)
Payments of assumed NYX debt and other acquisitions debt   (2.0)  
Payment of Financing and Stock Issuance Costs   0.0 0.0
Net cash (used in) provided by financing activities 12.0 (69.0) (417.0)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0.0 0.0 0.0
Increase (decrease) in cash, cash equivalents and restricted cash 9.0 (1.0) 3.0
Cash, cash equivalents and restricted cash, beginning of period 43.0 44.0 41.0
Cash, cash equivalents and restricted cash, end of period 52.0 43.0 44.0
Reportable Legal Entities | Non-Guarantor Subsidiaries      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 320.0 341.0 283.0
Cash flows from investing activities:      
Capital expenditures (123.0) (147.0) (81.0)
Distributions of capital from equity investments 23.0 30.0 34.0
Acquisitions and additions to equity method investments 0.0 (178.0) (107.0)
Other, principally change in intercompany investing activities 0.0    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     2.0
Payments for (Proceeds from) Other Investing Activities   0.0 120.0
Payments to Acquire Businesses, Net of Cash Acquired   (265.0) (32.0)
Proceeds from Sales of Assets, Investing Activities   0.0  
Net cash used in investing activities (100.0) (560.0)  
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds (2.0) (8.0) (304.0)
Net Payments For (Proceeds From) Long-Term Debt     7.0
Payments of debt issuance and deferred financing costs 1.0    
Payments on license obligations (2.0) 0.0 0.0
Sale of future revenue 0.0    
Net proceeds from the sale of SciPlay common stock 342.0    
Payments of deferred SciPlay common stock offering costs (9.0)    
Net redemptions of common stock under stock-based compensation plans and other (2.0) 0.0 0.0
Other, principally change in intercompany financing activities (426.0) 563.0 0.0
Payments of assumed NYX debt and other acquisitions debt   (288.0)  
Payment of Financing and Stock Issuance Costs   0.0 0.0
Net cash (used in) provided by financing activities (100.0) 267.0 (7.0)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.0 (6.0) 5.0
Increase (decrease) in cash, cash equivalents and restricted cash 121.0 42.0 (23.0)
Cash, cash equivalents and restricted cash, beginning of period 102.0 60.0 83.0
Cash, cash equivalents and restricted cash, end of period 223.0 102.0 60.0
Reportable Legal Entities | SGI      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 173.0 18.0 (300.0)
Cash flows from investing activities:      
Capital expenditures (28.0) (63.0) (31.0)
Distributions of capital from equity investments 0.0 0.0 0.0
Acquisitions and additions to equity method investments (1.0) (2.0) 0.0
Other, principally change in intercompany investing activities (289.0)    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     0.0
Payments for (Proceeds from) Other Investing Activities   159.0 569.0
Payments to Acquire Businesses, Net of Cash Acquired   0.0 0.0
Proceeds from Sales of Assets, Investing Activities   0.0  
Net cash used in investing activities 260.0 (224.0)  
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds (395.0) 246.0 (600.0)
Net Payments For (Proceeds From) Long-Term Debt     (958.0)
Payments of debt issuance and deferred financing costs 34.0    
Payments on license obligations (1.0) 0.0 0.0
Sale of future revenue 0.0    
Net proceeds from the sale of SciPlay common stock 0.0    
Payments of deferred SciPlay common stock offering costs 0.0    
Net redemptions of common stock under stock-based compensation plans and other (2.0) 0.0 0.0
Other, principally change in intercompany financing activities 0.0 0.0 0.0
Payments of assumed NYX debt and other acquisitions debt   0.0  
Payment of Financing and Stock Issuance Costs   (38.0) (59.0)
Net cash (used in) provided by financing activities (432.0) 208.0 899.0
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0.0 0.0 0.0
Increase (decrease) in cash, cash equivalents and restricted cash 1.0 2.0 (1.0)
Cash, cash equivalents and restricted cash, beginning of period 2.0 0.0 1.0
Cash, cash equivalents and restricted cash, end of period 3.0 2.0 0.0
Eliminating Entries      
Condensed Financial Statements, Captions [Line Items]      
Net cash (used in) provided by operating activities 1.0 2.0 (2.0)
Cash flows from investing activities:      
Capital expenditures 0.0 0.0 0.0
Distributions of capital from equity investments 0.0 0.0 0.0
Acquisitions and additions to equity method investments 0.0 0.0 0.0
Other, principally change in intercompany investing activities 289.0    
Increase (Decrease) In Other Operating Assets And Liabilities, Net, Including Proceeds From Asset Sales, Investing Activities     0.0
Payments for (Proceeds from) Other Investing Activities   (159.0) (689.0)
Payments to Acquire Businesses, Net of Cash Acquired   0.0 0.0
Proceeds from Sales of Assets, Investing Activities   0.0  
Net cash used in investing activities (289.0) 159.0  
Cash flows from financing activities:      
Payments on long-term debt, net of proceeds 0.0 0.0 689.0
Net Payments For (Proceeds From) Long-Term Debt     0.0
Payments of debt issuance and deferred financing costs 0.0    
Payments on license obligations 0.0 0.0 0.0
Sale of future revenue 0.0    
Net proceeds from the sale of SciPlay common stock 0.0    
Payments of deferred SciPlay common stock offering costs 0.0    
Net redemptions of common stock under stock-based compensation plans and other 0.0 0.0 0.0
Other, principally change in intercompany financing activities 289.0 (159.0) (689.0)
Payments of assumed NYX debt and other acquisitions debt   0.0  
Payment of Financing and Stock Issuance Costs   0.0 0.0
Net cash (used in) provided by financing activities 289.0 (159.0) (689.0)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 0.0 0.0 0.0
Increase (decrease) in cash, cash equivalents and restricted cash 1.0 2.0 (2.0)
Cash, cash equivalents and restricted cash, beginning of period (1.0) (3.0) (1.0)
Cash, cash equivalents and restricted cash, end of period $ 0.0 $ (1.0) $ (3.0)